Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Endocrine 1CNS 1

Conditions

Breast Neoplasms 1058Neoplasms 884Prostatic Neoplasms 510Lung Neoplasms 425Colorectal Neoplasms 359Motor Activity 226Head and Neck Neoplasms 195Uterine Cervical Neoplasms 192Carcinoma, Non-Small-Cell Lung 182Brain Neoplasms 175Pancreatic Neoplasms 162Ovarian Neoplasms 141Colonic Neoplasms 138Carcinoma, Hepatocellular 137Anxiety Disorders 124Rectal Neoplasms 119Hematologic Neoplasms 116Multiple Myeloma 109Stomach Neoplasms 104Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Melanoma 93Depression 93Urinary Bladder Neoplasms 88Pain 88Glioblastoma 87Endometrial Neoplasms 87Lymphoma 84Disease 84Sarcoma 78

Interventions

Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Essential Hypertension × 1 year × Clear all
NCT01022515 2026-02-06

PHEO

University Hospital, Rouen

Phase NA Completed
60 enrolled
CNSEndocrine

Essential Hypertension, Hypertension, Paraganglioma, Pheochromocytoma

NCT07375407 2026-02-02

Aerobic Exercise vs Physiological Ischemic Training in Stage 2 Hypertension

Universitas Padjadjaran

Phase NA Completed
60 enrolled
Lymphoid

Essential Hypertension, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡